Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study

BackgroundPrevious studies have confirmed the predicted value of serum glycated albumin (GA) in atherosclerotic cardiovascular disease. However, the relationship between GA and the development of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation has not been verified in patients...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xiao Long Lin, Qiu Yu Li, Dong Hui Zhao, Jing Hua Liu, Qian Fan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-09-01
Edice:	Frontiers in Cardiovascular Medicine
Témata:	glycated albumin (GA) in-stent restenosis (ISR) drug-eluting stents (DESs) acute coronary syndrome (ACS) percutaneous coronary intervention (PCI)
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.943185/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!